Peking University People's Hospital, Beijing, Beijing Municipality, 100044, China - 25 Apr `24Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo

Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo

Official title: Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo

Status: Recruiting now

Description:

To observe the long-term efficacy and safety of autologous non cultured epidermal cell suspension transplantation in the treatment of vitiligo, analyze the correlation between cell density, type, and postoperative efficacy and prognosis, and providing a basis for clinical application.

What is being studied: procedure — Autologous Non-cultured Epidermal Cell Suspension transplantation.

Who can take part: ages 8 Years to 65 Years, 30 participants planned.

Enrollment status: the registry has not updated this study since its planned completion date, so its current status is unclear. The study started 25 April 2024 and was due to finish 31 December 2025.

Source: ClinicalTrials.gov, NCT07187882 (https://clinicaltrials.gov/study/NCT07187882).

Start date: April 25, 2024

Completion date: December 31, 2025

Organizer: Peking University People's Hospital

Link: https://clinicaltrials.gov/study/NCT07187882

The registry does not list a contact for this study. Use the link above to reach the study record on ClinicalTrials.gov.

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions